Li, W., Chen, K., Du, J., Chen, X., Wang, D., He, K., Xu, C., Wu, M., Xu, M., Wang, B. (2025). Chidamide plus envafolimab combined with S-1 as second-line treatment in advanced and metastatic pancreatic cancer (P-henomS/SCOG-P002): A single-arm, exploratory, multicenter, phase 2 trial—Interim report.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.740